HCM IV Acquisition Corp. (NASDAQ:HACQ – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 15th, there was short interest totaling 44 shares, a decrease of 45.0% from the September 30th total of 80 shares. Based on an average daily volume of 74,474 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded shares of HCM IV Acquisition from a “sell (e)” rating to a “sell (e+)” rating in a report on Friday, October 9th. One research analyst has rated the stock with a Sell rating. According to MarketBeat, HCM IV Acquisition has an average rating of “Sell”.
Check Out Our Latest Research Report on HACQ
HCM IV Acquisition Price Performance
HCM IV Acquisition Company Profile
HCM IV Acquisition Corp. is a special purpose acquisition company (SPAC) organized to identify and complete a business combination with one or more operating companies. Its potential transactions may include a merger, acquisition, share exchange, asset acquisition, reorganization or similar corporate transaction.
As a SPAC, HCM IV Acquisition Corp. does not have an operating business, products or services of its own. Before completing a business combination, its activities are generally limited to evaluating potential targets, conducting due diligence and managing funds raised through its public offering.
Publicly available information about the company’s specific target focus, geographic operations and leadership is limited.
Recommended Stories
- Five stocks we like better than HCM IV Acquisition
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for HCM IV Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCM IV Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
